Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference
10. September 2020 08:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...
M2 Compliance to Sponsor Rodman & Renshaw 21st Annual Global Investment Conference
06. September 2019 17:19 ET
|
M2 Compliance
Los Angeles, CA, Sept. 06, 2019 (GLOBE NEWSWIRE) -- M2 Compliance ("M2"), a leading SEC registered filing agent, and financial printer will be proudly sponsoring the Rodman & Renshaw Conference,...
Emerald Health Therapeutics fera une présentation lors de la 21e conférence mondiale annuelle sur les investissements de Rodman & Renshaw
28. August 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 28 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) a annoncé aujourd'hui qu'elle présentera un aperçu...
Emerald Health Therapeutics to Present at Rodman & Renshaw 21st Annual Global Investment Conference
28. August 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that it will present a corporate overview and...
M2 to Sponsor the 20th Annual Global Investment Conference Hosted by Rodman & Renshaw (H.C. Wainwright & Co.)
03. September 2018 20:44 ET
|
M2 Compliance
New York, Sept. 03, 2018 (GLOBE NEWSWIRE) -- M2 Compliance ("M2"), a global leading SEC registered filing agent and financial printer, announced it will be proudly sponsoring the 20th Annual Global...
Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018
28. August 2018 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a company focused on developing new technologies to achieve step-change improvements in crop yield to enhance...
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28. August 2018 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
Advanced Emissions Solutions to Present at Rodman & Renshaw Global Investment Conference
05. September 2017 16:30 ET
|
Advanced Emissions Solutions, Inc.
HIGHLANDS RANCH, Colo., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Advanced Emissions Solutions, Inc. (NASDAQ:ADES) (the "Company" or "ADES") today announced that the Company will be presenting at the...
Yield10 Bioscience to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
05. September 2017 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company focused on developing new technologies to achieve step-change improvements in crop yield to...
Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
05. September 2017 08:30 ET
|
Galectin Therapeutics
NORCROSS, Ga., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will...